Navigation Links
New Insights, Inroads Against Breast, Ovarian Cancers
Date:5/31/2009

urham, N.C. Still, "I doubt every treating oncologist will stop using this to follow treatment."

Another oncologist agreed. "This study suggests that early detection of metastatic cancer did not improve survival," said Dr. Claudine Isaacs, a medical oncologist with Georgetown's Lombardi Comprehensive Cancer Center in Washington, D.C. Unfortunately, the usefulness of CA125 in initial cervical cancer screening remains "questionable."

But there was good news at the meeting for women battling tough-to-treat breast cancers.

Two new studies found promising results with an entirely new class of drugs, called PARP inhibitors -- the first targeted therapy for so-called "triple-negative" breast cancer. Currently, the 15 percent of breast cancer patients who have this type of aggressive tumor have only the option of surgery and chemotherapy.

Breast cancers associated with the BRCA1 and BRCA 2 gene mutations (which heighten risk) are almost always triple negative, explained Dr. Joyce O'Shaughnessy, lead author of one of the studies and co-director of the Breast Cancer Research Program at Baylor-Charles A. Sammons Cancer Center in Dallas.

About 30 percent of women with triple negative cancer experience a recurrence and, once that happens, only survive a year or so.

In this phase II trial, half of the 120 women with this form of metastatic breast cancer were randomized to receive chemo alone, the other half to chemo plus the PARP inhibitor BSI-201.

Those receiving the combination therapy saw almost a doubling of their survival -- from 5.7 months with chemo alone to 9.2 months when BSI-201 was added in, as well as about a 60 percent reduction in the risk of dying from the disease. There were also no additional side effects as compared with standard chemo.

The second phase II PARP inhibitor trial involved 54 women with advance breast cancer who carried the BRCA1/2 mutations. In this trial, t
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. MedInsights, Inc. Selects Douglas Young as VP - Sales & Product Development
2. EMBASE Classic Makes Inroads into Pharmaceutical Industry
3. EMBASE Classic makes inroads into pharmaceutical industry
4. Small Health Plans Making Inroads in Florida Marketplace
5. Genetic Medicine Making Inroads Against Disease
6. Science Makes Inroads Against Prostate, Other Cancers
7. Experts Highlight Inroads to Preventing Cancer
8. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
9. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
10. Despite overeating, morbidly obese mice gain protection against diabetes
11. Alvarado Hospital Files Countersuit Against Blue Shield
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Insights, Inroads Against Breast, Ovarian Cancers
New Insights, Inroads Against Breast, Ovarian Cancers
(Date:12/16/2009)... A diet rich in methionine, an amino acid ... garlic, lentils, onions, yogurt and seeds, can possibly ... to a study by Temple researchers. , The ... Amyloid-β formation and deposition in a mouse model ... Alzheimer Research . , "When methionine reaches too ...
(Date:12/16/2009)... employers strongly indicates that wellness programs have a positive impact ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- ... percent of employers have improved employee participation in health and ... the survey, conducted by Hallmark Insights, a leader in incentive-driven ...
(Date:12/16/2009)... is honored to announce that Chris Wepfer and Jackie Kirby ... in Healthcare Traveler magazine’s 2009 Recruiters of the Year Showcase. ... such honors and the first for Jackie. , ... ... a national healthcare staffing agency, is honored to announce that ...
(Date:12/16/2009)... 16 Tyco International Ltd. (NYSE: ... Michael E. Daniels for election to the Tyco ... Meeting on March 10, 2010. ,, Daniels, ... Technology Services group of International Business Machines Corporation. ... IBM,s Global Services business operations consisting of outsourcing ...
(Date:12/16/2009)... Dec. 16 Sermo ( http://www.sermo.com ), ... announced the results of a new Sermo Vitals ... ." The report examines physician dialog about ... complete analysis of a variety of topics, including ... they prefer, and candid/verbatim comments on issues related ...
Breaking Medicine News(10 mins):Health News:Diet high in methionine could increase risk of Alzheimer's 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3
... have a long-term positive impact on sexual behavior in ... RAND Corporation study. , Researchers found that young adults ... prevention program as adolescents were less likely to engage ... according to the findings published online by the ...
... Test Will Focus on 4.3 Million Annual U.S. Birth ... (OTC Bulletin Board: BMSN) and Entest BioMedical Inc., BMSN,s ... signed with Dr. Brian Koos, a professor of Obstetrics ... at UCLA for the development, refinement, and ...
... PA Breast Cancer Coalition holds press conferenceEPHRATA, Pa., April 29 ... is available to women diagnosed with breast cancer in Pennsylvania ... and many healthcare providers - are not aware of the ... That,s why the Pennsylvania Breast Cancer Coalition (PBCC), in partnership ...
... Waters Corporation (NYSE: WAT ... Administration (U.S. DEA) purchased a Waters(R) ACQUITY(R) UltraPerformance Liquid ... at the Special Testing and Research Laboratory in Dulles, ... state and federal law enforcement agencies in monitoring and ...
... the U.S. confronts a potential pandemic disease, the Council ... urges Congress to support innovation agendaWASHINGTON, April 29 ... first flu pandemic in more than 50 years, the ... for his commitment to medical innovation since taking office ...
... Care has been selected as the lead organizational and strategic planning consultant. ... the planning and development of the new healthcare delivery organization. , ... ... a 366 bed acute care hospital. The hospital will be part ...
Other Medicine News:Health News:Teen drug education also helps curb risky sexual behavior, study finds 2Health News:Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test 2Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:Waters Corporation Announces U.S. Drug Enforcement Administration Acquires Waters ACQUITY UPLC System to Train Forensic Chemists in Drug Screening and Profiling 2Health News:Coalition of Leaders in Science and Research Commend Obama Administration for Commitment to Medical Innovation During 'First 100 Days' 2Health News:Coalition of Leaders in Science and Research Commend Obama Administration for Commitment to Medical Innovation During 'First 100 Days' 3
(Date:12/16/2009)... WAYNE, N.J., Dec. 16 MAQUET ... technologies, today announced that it has signed ... Novation, the industry,s leading supply contracting company, ... (EVH) Systems. The VASOVIEW products assist healthcare ... blocked coronary arteries using only small incisions. ...
(Date:12/16/2009)... 16 Naurex Inc., a new clinical ... other CNS disorders based on its novel GFPA ... initiated a Phase I clinical trial of its ... first subjects in the study. GLYX-13, a ... of the NMDA receptor, is initially being developed ...
(Date:12/16/2009)... Texas, Dec. 16 Savara, Inc., an inhalation ... the second tranche in its Series A financing round, ... ,, Funds raised in the Series A ... the NanoCluster technology. ,, "We now have the ... performance of the NanoCluster technology," said Rob Neville, CEO ...
Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2Social Isolation Adversely Affects Breast Cancer 58478 1Social Isolation Adversely Affects Breast Cancer 58478 2Social Isolation Adversely Affects Breast Cancer 58478 3Women fare better than men with metastatic colorectal cancer are hormones helping 3F 58474 1Women fare better than men with metastatic colorectal cancer are hormones helping 3F 58474 2Young adults may outgrow bipolar disorder 58470 1Young adults may outgrow bipolar disorder 58470 2
... humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody seeking approval to ... ... Roche announced today the,submission of a biologics license application (BLA) ... ACTEMRA(R),(tocilizumab) to reduce the signs and symptoms in adults with moderate ...
... programming is superior,to cloning as a means of ... Two major scientific,papers published this week in ... patient-matched human pluripotent stem cells without human,cloning, and ... or animal eggs.,Research groups in Wisconsin and Japan ...
Other Medicine Technology:Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis 2Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis 3Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3
The Auto Suture&trade ENDO RETRACT&trade Maxi instrument has application in a variety of general, thoracic, gynecologic, urologic, and endoscopic procedures for temporary retracting of tissue and sma...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: